NCT05795335Recruiting
CDK4/6 Inhibitors in Patients With Hormone Receptor-positive Advanced Breast Cancer
Survival Outcomes, Adverse Events and Predictive Biomarkers for CDK4/6 Inhibitors in Patients With Hormone Receptor-positive Advanced Breast Cancer, an Ambispective Single-center Cohort Study
Source: ClinicalTrials.gov · Last updated 16 May 2023 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This is an ambispective, single-center study to evaluate the survival outcomes, adverse events and predictive biomarkers for CDK4/6 inhibitors in patients with hormone receptor-positive advanced breast cancer.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 172 (estimated)
- First submitted
- 21 Mar 2023
- Start date
- 30 Apr 2023
- Primary completion date
- 30 Apr 2026
- Lead sponsor
- RenJi Hospital
- Diseases
- Metastatic breast cancer
- NCT number
- NCT05795335
What you commit to
- Study type: Observational
- Planned participants: 172
- From 30 Apr 2023 to the primary completion date, 30 Apr 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- History of immunodeficiency disease
Other
- Subjects disable to swallow pills.
Who the study is looking for
- Aged ≥18 and older
- Confirmed diagnosis of hormone receptor-positive breast cancer.
- Subjects with locoregionally recurrent or metastatic disease not amenable to curative therapy.
- Subjects have received or plan to receive CDK4/6 inhibitors for advanced disease.
- ECOG 0-2
- Adequate organ function
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Renji Hospital, School of Medicine, Shanghai Jiao Tong University Coordinator of this site? Confirm its status | Shanghai | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.